Filing metadata

Accession number
0001214659-22-000858
Form type
Form 4
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Jan 18, 2022
Reporting period
Jan 14, 2022
Description
Insider transaction

Explore SEC Filings Hub